Pular para o conteúdo
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Título
Autor
Assunto
Número de Chamada
ISBN/ISSN
Tag
Buscar
Avançada
Do Diuretics, Beta-Blockers, a...
Citar
Enviar por SMS
Enviar por e-mail
Imprimir
Exportar registro
Exportar para RefWorks
Exportar para EndNoteWeb
Exportar para EndNote
Link permanente
Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study
Detalhes bibliográficos
Principais autores:
Shen, L
,
Shah, B
,
Reyes, E
,
Thomas, L
,
Diem, P
,
Leiter, L
,
Charbonnel, B
,
Mareev, V
,
Horton, E
,
Haffner, S
,
Soska, V
,
Holman, R
,
Bethel, M
,
Schaper, F
,
Sun, J
,
McMurray, J
,
Califf, R
,
Krum, H
Formato:
Journal article
Publicado em:
2012
Itens
Descrição
Registros relacionados
Registro fonte
Registros relacionados
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.
por: Shen, L, et al.
Publicado em: (2013)
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study.
por: McMurray, J, et al.
Publicado em: (2012)
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study
por: Mcmurray, J, et al.
Publicado em: (2012)
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
por: Krum, H, et al.
Publicado em: (2010)
Association of non-alcoholic steatothepatitis with components of the metabolic syndrome in 43,509 patients screened for NAVIGATOR
por: Bethel, A, et al.
Publicado em: (2005)